Home > Cashflow Statement > VENUS REMEDIES

VENUS REMEDIES
Cashflow Statement

VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

VENUS REMEDIES Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹62 Cr₹45 Cr₹38 Cr₹36 Cr₹25 Cr
Adjustment ₹15 Cr₹20 Cr₹23 Cr₹26 Cr₹22 Cr
Changes In working Capital ₹25 Cr₹-12 Cr₹-25 Cr₹-22 Cr₹61 Cr
Cash Flow after changes in Working Capital ₹101 Cr₹53 Cr₹37 Cr₹41 Cr₹108 Cr
Cash Flow from Operating Activities ₹86 Cr₹37 Cr₹37 Cr₹41 Cr₹132 Cr
Cash Flow from Investing Activities ₹-76 Cr₹-7.21 Cr₹-51 Cr₹-17 Cr₹56 Cr
Cash Flow from Financing Activities ₹-1.02 Cr₹-1.08 Cr₹-0.57 Cr₹-9.48 Cr₹-162 Cr
Net Cash Inflow / Outflow ₹9.18 Cr₹29 Cr₹-15 Cr₹15 Cr₹26 Cr
Opening Cash & Cash Equivalents ₹49 Cr₹21 Cr₹43 Cr₹29 Cr₹1.94 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹-0.61 Cr₹-1.25 Cr₹-7.27 Cr₹-0.52 Cr₹0.85 Cr
Closing Cash & Cash Equivalent ₹58 Cr₹49 Cr₹21 Cr₹43 Cr₹29 Cr

Compare Cashflow Statement of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹947.8 Cr -10.5% -5.7% 144.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,217.0 Cr 0.4% 5.6% 1.8% Stock Analytics
DIVIS LABORATORIES ₹166,047.0 Cr -0.5% 3.3% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,872.0 Cr 4.5% 10% 41.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,454.0 Cr 1.5% 4.8% 9.1% Stock Analytics
CIPLA ₹107,136.0 Cr -1.7% 1% -10.5% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-10.5%

-5.7%

144.2%

SENSEX

-1.5%

0.8%

8.2%


You may also like the below Video Courses